Queen Mary University of London: New Class of Drug Leads to 30 Per Cent Reduced Risk of Death for Bladder Cancer Patients
February 18, 2021
February 18, 2021
LONDON, England, Feb. 18 (TNSJou) -- Queen Mary University of London issued the following news:
A new type of drug that helps target chemotherapy directly to cancer cells has been found to significantly increase survival of patients with the most common form of bladder cancer, according to results from a phase III clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust.
The results are published in the New England Journal of Medicine a . . .
A new type of drug that helps target chemotherapy directly to cancer cells has been found to significantly increase survival of patients with the most common form of bladder cancer, according to results from a phase III clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust.
The results are published in the New England Journal of Medicine a . . .